BioSpace News Archive

NextCure, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, announced that it will present at the BTIG Virtual Biotechnology Conference on August 11th at 9:30 am Eastern time.

Alan Smith, Ph.D., Joins as Chief Technology Officer Saira Ramasastry Joins Board of Directors; Arthur Tzianabos, Ph.D., Role Expanded to Chairman

Interim Analysis Indicates Decreased Number of Diverticula and Healthy Tissue

Pfizer Canada and BioNTech SE today announced an agreement with the Government of Canada to supply their BNT162 mRNA-based vaccine candidate against SARS-CoV2, subject to clinical success and Health Canada approval.

Vericel Corporation, a leader in advanced therapies for the sports medicine and severe burn care markets, reported financial results and business highlights for the second quarter ended June 30, 2020.

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that Chief Executive Officer John Valliant , Ph.D., will present a company overview at the 2020 Wedbush PacGrow Healthcare Virtual Conference

Pall Corporation, a global leader in filtration, separation and purification, was selected by the United States Department of Defense to receive a $4.9M contract to build a new breathing filter manufacturing line within an existing U.S.-based Pall manufacturing facility to increase ventilator filter production.

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today introduced a new highly automated, real-time PCR solution designed to analyze up to 6,000 samples in a single day to meet increasing global demand for COVID-19 testing. The high-throughput system enables laboratories to double or even triple their te

For the six months ended June 30, 2020, Net Revenues Increase 104% and Operating Expenses Decrease by 17% Peer-Reviewed Research Published, Launch of AAVSB-Accredited Veterinary Continuing Education Program and Wide-Ranging Distribution Agreements with Key Partners Lay the Foundation for Sustained Growth.

Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary aesthetic platform technology, today announced the appointment of Dr. Sachin Shridharani to its Scientific Advisory Board, effective immediately.